BioNexus Gene Lab Corp. (BGLC)
NASDAQ: BGLC · Real-Time Price · USD
3.050
+0.080 (2.69%)
May 15, 2025, 3:30 PM - Market open
BioNexus Gene Lab Market Cap
BioNexus Gene Lab has a market cap or net worth of $5.48 million as of May 15, 2025. Its market cap has decreased by -47.74% in one year.
Market Cap
5.48M
Enterprise Value
1.19M
1-Year Change
-47.74%
Ranking
Category
Stock Price
$3.05
Market Cap Chart
Since September 16, 2020, BioNexus Gene Lab's market cap has decreased from $42.12M to $5.48M, a decrease of -86.99%. That is a compound annual growth rate of -35.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 13, 2025 | 5.48M | 9.04% |
| Dec 31, 2024 | 5.03M | -46.33% |
| Dec 29, 2023 | 9.36M | -94.33% |
| Dec 30, 2022 | 165.03M | -54.75% |
| Dec 31, 2021 | 364.69M | 54.35% |
| Dec 31, 2020 | 236.28M | 460.98% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Linde | 212.14B |
| BHP Group | 128.62B |
| Rio Tinto Group | 106.96B |
| The Sherwin-Williams Company | 89.04B |
| Southern Copper | 75.01B |
| Ecolab | 71.30B |
| CRH plc | 66.30B |
| Air Products and Chemicals | 60.90B |